{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:48:35Z","timestamp":1775645315568,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10384-024-01067-1","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T05:01:28Z","timestamp":1717477288000},"page":"346-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selective ophthalmic arterial injection using a balloon catheter for retinoblastoma: a seven-year clinical evaluation"],"prefix":"10.1007","volume":"68","author":[{"given":"Sota","family":"Oguro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Mohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-2045","authenticated-orcid":false,"given":"Shigenobu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/jamaoncol.2019.6716","volume":"6","author":"ID Fabian","year":"2020","unstructured":"Global Retinoblastoma Study Group, Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, et al. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol. 2020;6:685\u201395.","journal-title":"JAMA Oncol"},{"key":"1067_CR2","doi-asserted-by":"crossref","unstructured":"Jehanne M, Lumbroso-Le Rouic L, Savignoni A, Aerts I, Mercier G, Bours D et al. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer. 2009;52637\u201343.","DOI":"10.1002\/pbc.21898"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0360-3016(97)00156-9","volume":"39","author":"DG Pradhan","year":"1997","unstructured":"Pradhan DG, Sandridge AL, Mullaney P, Abboud E, Karcioglu ZA, Kandil A, et al. Radiation therapy for retinoblastoma: a retrospective review of 120 patients. Int J Radiat Oncol Biol Phys. 1997;39:3\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/jnci\/85.14.1121","volume":"85","author":"C Eng","year":"1993","unstructured":"Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85:1121\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/0975-5950.183871","volume":"6","author":"V Shah","year":"2015","unstructured":"Shah V, Yadav L, Singh M, Kharbanda S. Custom ocular prosthesis in rehabilitation of a child operated for retinoblastoma. Natl J Maxillofac Surg. 2015;6:232\u20136.","journal-title":"Natl J Maxillofac Surg"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.4103\/ijo.IJO_721_20","volume":"68","author":"D Ancona-Lezama","year":"2020","unstructured":"Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: a 2020 review. Indian J Ophthalmol. 2020;68:2356\u201365.","journal-title":"Indian J Ophthalmol"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s10384-015-0378-0","volume":"59","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Aihara Y, Fujiwara M, Sano S, Kaneko A. Intravitreal injection of melphalan for intraocular retinoblastoma. Jpn J Ophthalmol. 2015;59:164\u201372.","journal-title":"Jpn J Ophthalmol"},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0002-9394(00)00407-4","volume":"129","author":"SR Anagnoste","year":"2000","unstructured":"Anagnoste SR, Scott IU, Murray TG, Kramer D, Toledano S. Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy. Am J Ophthalmol. 2000;129:817\u20139.","journal-title":"Am J Ophthalmol"},{"key":"1067_CR9","first-page":"858","volume":"78","author":"M Inomata","year":"1987","unstructured":"Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res. 1987;78:858\u201368.","journal-title":"Jpn J Cancer Res"},{"key":"1067_CR10","first-page":"679","volume":"70","author":"M Mohri","year":"1993","unstructured":"Mohri M. The development of a new system of selective ophthalmic arterial infusion for the patients of intraocular retinoblastoma. Keio Igaku [J Keio Soc]. 1993;70:679\u201387. (in Japanese).","journal-title":"Keio Igaku [J Keio Soc]"},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","volume":"118","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118:2081\u20137.","journal-title":"Ophthalmology"},{"key":"1067_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10147-004-0392-6","volume":"9","author":"T Yamane","year":"2004","unstructured":"Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9:69\u201373.","journal-title":"Int J Clin Oncol"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1755-3768.2011.02296.x","volume":"91","author":"C Venturi","year":"2013","unstructured":"Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, Gennari P, et al. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol. 2013;91:335\u201342.","journal-title":"Acta Ophthalmol"},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3171\/2011.1.JNS10466","volume":"114","author":"EC Peterson","year":"2011","unstructured":"Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg. 2011;114:1603\u20138.","journal-title":"J Neurosurg"},{"key":"1067_CR15","doi-asserted-by":"publisher","first-page":"e12676","DOI":"10.1097\/MD.0000000000012676","volume":"97","author":"L Wang","year":"2018","unstructured":"Wang L, Han M, Zhao J, Wu C, Wang Z, Li J, et al. Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: results and short-term complications. Med (Baltim). 2018;97:e12676.","journal-title":"Med (Baltim)"},{"key":"1067_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/neurintsurg-2020-016759","volume":"13","author":"A Sweid","year":"2021","unstructured":"Sweid A, El Naamani K, Sajja KC, Hammoud B, Knapp MD, Moylan DD, et al. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2021;13:652\u20136.","journal-title":"J Neurointerv Surg"},{"key":"1067_CR17","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1136\/bjophthalmol-2021-319118","volume":"106","author":"M Zhou","year":"2022","unstructured":"Zhou M, Wen X, Jia S, Han Y, He X, Han M, et al. Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy. Br J Ophthalmol. 2022;106:1581\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1067_CR18","unstructured":"White A, Hope WEC. Oct. Staging and Classification for Intraocular Blastoma. https:\/\/wechope.org\/retinoblastoma\/staging-and-classification-for-intraocular-retinoblastoma\/. Accessed 10 2023."},{"key":"1067_CR19","unstructured":"National Cancer Institute, National Institutes of Health, United States Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE). version 5.0; November 27 2017. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed 10 Oct 2023."},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10384-014-0356-y","volume":"59","author":"SJ Ong","year":"2015","unstructured":"Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review. Jpn J Ophthalmol. 2015;59:109\u201317.","journal-title":"Jpn J Ophthalmol"},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.radcr.2022.09.004","volume":"17","author":"P Sidipratomo","year":"2022","unstructured":"Sidipratomo P, Pandelaki J, Matondang SBRE, Ramandika H, Sitorus RS, Karismaputri KS, et al. Intra-arterial chemotherapy for retinoblastoma: our first experience in Indonesia. Radiol Case Rep. 2022;17:4713\u20136.","journal-title":"Radiol Case Rep"},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4143\/crt.2021.1537","volume":"55","author":"JW Han","year":"2023","unstructured":"Han JW, Lee CS, Hahn SM, Ahn WK, Kim HS, Yun H, et al. The efficacy of alternate systemic intravenous chemotherapy and intra-arterial chemotherapy approach for eye globe salvage in retinoblastoma. Cancer Res Treat. 2023;55:270\u20138.","journal-title":"Cancer Res Treat"},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/neurintsurg-2022-018957","volume":"15","author":"JA Carnevale","year":"2023","unstructured":"Carnevale JA, Goldberg J, Kocharian G, Rivera M, Giantini Larsen A, Garton A, et al. Intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2023;15:303\u20134.","journal-title":"J Neurointerv Surg"},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"e44322","DOI":"10.1371\/journal.pone.0044322","volume":"7","author":"YP Gobin","year":"2012","unstructured":"Gobin YP, Dunkel IJ, Marr BP, Francis JH, Brodie SE, Abramson DH. Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma. PLoS ONE. 2012;7:e44322.","journal-title":"PLoS ONE"},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jamaophthalmol.2015.3108","volume":"133","author":"DH Abramson","year":"2015","unstructured":"Abramson DH, Shields CL, Munier FL, Chantada GL. Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol. 2015;133:1341\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/13816810.2016.1227995","volume":"38","author":"H Elzomor","year":"2017","unstructured":"Elzomor H, Taha H, Nour R, Aleieldin A, Zaghloul MS, Qaddoumi I, et al. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. Ophthalmic Genet. 2017;38:345\u201351.","journal-title":"Ophthalmic Genet"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01067-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01067-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01067-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T16:12:13Z","timestamp":1724775133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01067-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01067-1","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. Oguro, None; Y. N. Chen, None; T. Yamane, None; M. Mohri, None; S. Suzuki, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}